Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001574133-13-000001
Filing Date
2013-04-16
Accepted
2013-04-16 15:55:08
Documents
1
Effectiveness Date
2013-04-16
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7383
  Complete submission text file 0001574133-13-000001.txt   8423
Mailing Address 1380 - 112TH AVE. NE, SUITE 200 BELLEVUE WA 98004
Business Address 1380 - 112TH AVE. NE, SUITE 200 BELLEVUE WA 98004 (425) 269-3478
BEAT BioTherapeutics Corp (Filer) CIK: 0001574133 (see all company filings)

EIN.: 264819893 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-195092 | Film No.: 13763969